| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Island Pharmaceuticals Limited (AU: ILA)
ILA Technical Analysis
5
| As on 19th Nov 2025 ILA STOCK Price closed @ 0.49 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.13 & Strong Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ILASTOCK Price
| Open | 0.52 | Change | Price | % |
| High | 0.53 | 1 Day | -0.04 | -7.55 |
| Low | 0.48 | 1 Week | 0.01 | 2.08 |
| Close | 0.49 | 1 Month | 0.07 | 16.67 |
| Volume | 822186 | 1 Year | 0.43 | 716.67 |
| 52 Week High 0.52 | 52 Week Low 0.06 | ||||
AU Australia Most Active Stocks
| HLX | 0.00 | % |
| CXO | 0.22 | 0.00% |
| NTU | 0.03 | 0.00% |
| DRO | 1.97 | -19.59% |
| ATC | 0.02 | -33.33% |
| LKE | 0.06 | 20.00% |
| PLS | 3.98 | -2.69% |
| MEL | 0.00 | % |
| VR1 | 0.04 | 33.33% |
| AGY | 0.07 | 16.67% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| ILA Daily Charts |
ILA Intraday Charts |
Whats New @ Bazaartrend |
ILA Free Analysis |
|
|
ILA Important Levels Intraday
| RESISTANCE | 0.59 |
| RESISTANCE | 0.56 |
| RESISTANCE | 0.54 |
| RESISTANCE | 0.52 |
| SUPPORT | 0.46 |
| SUPPORT | 0.44 |
| SUPPORT | 0.42 |
| SUPPORT | 0.39 |
ILA Forecast November 2025
| 4th UP Forecast | 0.51 |
| 3rd UP Forecast | 0.5 |
| 2nd UP Forecast | 0.5 |
| 1st UP Forecast | 0.5 |
| 1st DOWN Forecast | 0.48 |
| 2nd DOWN Forecast | 0.48 |
| 3rd DOWN Forecast | 0.48 |
| 4th DOWN Forecast | 0.47 |
ILA Weekly Forecast
| 4th UP Forecast | 0.49 |
| 3rd UP Forecast | 0.49 |
| 2nd UP Forecast | 0.49 |
| 1st UP Forecast | 0.49 |
| 1st DOWN Forecast | 0.49 |
| 2nd DOWN Forecast | 0.49 |
| 3rd DOWN Forecast | 0.49 |
| 4th DOWN Forecast | 0.49 |
ILA Forecast2025
| 4th UP Forecast | 1.53 |
| 3rd UP Forecast | 1.2 |
| 2nd UP Forecast | 0.99 |
| 1st UP Forecast | 0.78 |
| 1st DOWN Forecast | 0.2 |
| 2nd DOWN Forecast | -0.01 |
| 3rd DOWN Forecast | -0.22 |
| 4th DOWN Forecast | -0.55 |
Island Pharmaceuticals Limited ( AU Australia Symbol : ILA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ILA Other Details
| Segment | EQ | |
| Market Capital | 25909918.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
ILA Address
![]() |
||
ILA Latest News
ILA Business Profile
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. Island Pharmaceuticals Limited has a research collaboration agreement with Monash University to screen known molecules against host targets; research and development collaboration with Griffith University to screen for active anti-viral molecules in a rational repurposing strategy; research collaboration agreement with Compounds Australia, a drug library containing approximately four and a half thousand molecules that could be searched for drug re-purposing and pipeline development; cooperative research and development agreement with the U.S. Army in preparation for its Phase II clinical study for ISLA-101; supply agreement with Catalent for manufacture of Fenretinide softgels for dengue fever trial participants; and right to reference National Cancer Institute IND for Isla101. The company was founded in 2017 and is based in Camberwell, Australia. Address: 697 Burke Road, Camberwell, VIC, Australia, 3124
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

